Home GLP-1

Tag: GLP-1

A magnifying glass held over the word “GLP-1” with surrounding text such as “Semaglutide,” “Obesity,” and “weight loss,” representing a medical or pharmaceutical focus.

May 07, 2025

ZyVersa Therapeutics Advances IC 100 as Complementary Therapy to GLP-1 Agonists for Obesity-Related Inflammation

The clinical-stage biopharmaceutical company, ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA), is advancing its novel inflammasome ASC inhibitor, IC 100, as a potential adjunct therapy to GLP-1…

Nasdaq Most Active

Tag: GLP-1

ZyVersa Therapeutics Advances IC 100 as Complementary Therapy to GLP-1 Agonists for Obesity-Related Inflammation

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Tag: GLP-1

ZyVersa Therapeutics Advances IC 100 as Complementary Therapy to GLP-1 Agonists for Obesity-Related Inflammation

PRISM Market View Alerts

Get your dose of PRISM Market View news, right in your inbox

Get your dose of PRISM Market
View news, right in your inbox